ABCL: the cashflow

MyFinsight

For the quarter ending 2025-09-30, ABCL had -$9,278K decrease in cash & cash equivalents over the period. -$61,522K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-57,119	-80,348
Depreciation of property and equipment	4,306	8,951
Amortization and impairment of intangible assets	940	1,851
Amortization of operating lease right-of-use assets	1,990	2,863
Stock-based compensation	13,895	28,993
Fair value (gain)/loss on contingent consideration	-613	-
Other	-1,655	667
Research fees and grants receivable	3,433	12,524
Income taxes payable (receivable)	-12,204	-7,588
Accounts payable and accrued liabilities	5,070	-7,356
Deferred revenue	-7,045	9,361
Deferred grant income	1,153	1,681
Fair value gain on contingent consideration	-	-737
Other assets	-628	-13,450
Net cash used in operating activities	-52,594	-43,958
Purchases of property and equipment	8,928	24,001
Purchase of marketable securities	33,162	291,542
Proceeds from marketable securities	83,099	303,437
Receipt of grant funding	918	6,448
Long-term investments and other assets	2,988	13,783
Investment in equity accounted investees	2,451	4,435
Net cash provided by investing activities	36,488	-23,876
Payment of liability for in-licensing agreement and other	9,240	-
Proceeds from other liabilities and exercise of stock options	7,554	11,653
Payment of contingent consideration and other	-	9,058
Net cash provided by financing activities	7,372	2,595
Effect of exchange rate changes on cash and cash equivalents	-544	1,351
Decrease in cash and cash equivalents	-9,278	-63,888
Cash and cash equivalents at beginning of period	183,615	-
Cash and cash equivalents at end of period	110,449	-

Unit: Thousand (K) dollars